Literature DB >> 33989065

A Scoping Review of Behavioral Interventions Addressing Medical Financial Hardship.

Minal R Patel1,2, Reshma Jagsi2,3,4, Kenneth Resnicow1,2, Shawna N Smith5, Lauren M Hamel6, Christopher Su2,7, Jennifer J Griggs2,5,7,8, Diamond Buchanan1, Nicole Isaacson1, Michelle Torby1.   

Abstract

Little information has been compiled across studies about existing interventions to mitigate issues of medical financial hardship, despite growing interest in health care delivery. The purpose of this qualitative systematic scoping review was to examine content and outcomes of interventions to address medical financial hardship. PRISMA guidelines were applied to present results using PubMed, Scopus, and CINAHL, published between January 1980 and August 2020. Additional studies were identified through reference lists of selected papers. Included studies focused on mitigating medical financial hardship from out-of-pocket (OOP) health care expenses as an intervention strategy with at least 1 evaluation component. Screening 2412 articles identified 339 articles for full-text review, 12 of which met inclusion criteria. Variation was found regarding targets and outcome measurement of intervention. Primary outcomes were in the following categories: financial outcomes (eg, OOP expenses), behavioral outcomes, psychosocial, health care utilization, and health status. No included studies reported significant reduction in OOP expenses, perceptions of financial burden/toxicity, or health status. However, changes were observed for behavioral outcomes (adherence to treatment, patient needs addressed), some psychosocial outcomes (mental health symptoms, perceived support, patient satisfaction), and care utilization such as routine health care. No patterns were observed in the achievement of outcomes across studies based on intensity of intervention. Few rigorous studies exist in this emerging field, and studies have not shown consistent positive effects. Future research should focus on conceptual clarity of the intervention, align outcome measurement and achieve consensus around outcomes, and employ rigorous study designs, measurement, and outcome follow-up.

Entities:  

Keywords:  financial toxicity; health care; interventions; medical financial hardship

Mesh:

Year:  2021        PMID: 33989065      PMCID: PMC8713277          DOI: 10.1089/pop.2021.0043

Source DB:  PubMed          Journal:  Popul Health Manag        ISSN: 1942-7891            Impact factor:   2.459


  47 in total

Review 1.  Direct and indirect cost of managing alzheimer's disease and related dementias in the United States.

Authors:  Arijita Deb; James Douglas Thornton; Usha Sambamoorthi; Kim Innes
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2017-04       Impact factor: 2.217

2.  Patient perceptions of asthma-related financial burden: public vs. private health insurance in the United States.

Authors:  Minal R Patel; Cleopatra H Caldwell; Peter X K Song; John R C Wheeler
Journal:  Ann Allergy Asthma Immunol       Date:  2014-08-01       Impact factor: 6.347

3.  Pilot Feasibility Study of an Oncology Financial Navigation Program in Brain Cancer Patients.

Authors:  Gelareh Sadigh; Kathleen Gallagher; Jennifer Obenchain; Al Benson; Edith Mitchell; Soma Sengupta; Ruth C Carlos
Journal:  J Am Coll Radiol       Date:  2019-10       Impact factor: 5.532

4.  Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer.

Authors:  Scott D Ramsey; Aasthaa Bansal; Catherine R Fedorenko; David K Blough; Karen A Overstreet; Veena Shankaran; Polly Newcomb
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

5.  Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries.

Authors:  Reshma Jagsi; John A E Pottow; Kent A Griffith; Cathy Bradley; Ann S Hamilton; John Graff; Steven J Katz; Sarah T Hawley
Journal:  J Clin Oncol       Date:  2014-03-24       Impact factor: 44.544

6.  Material-Psychosocial-Behavioral Aspects of Financial Hardship: A Conceptual Model for Cancer Prevention.

Authors:  Reginald D Tucker-Seeley; Roland J Thorpe
Journal:  Gerontologist       Date:  2019-05-17

7.  Designing and Testing Apps to Support Patients With Cancer: Looking to Behavioral Science to Lead the Way.

Authors:  Lauren M Hamel; Hayley S Thompson; Terrance L Albrecht; Felicity Wk Harper
Journal:  JMIR Cancer       Date:  2019-04-22

8.  Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications.

Authors:  J Witte; K Mehlis; B Surmann; R Lingnau; O Damm; W Greiner; E C Winkler
Journal:  Ann Oncol       Date:  2019-07-01       Impact factor: 32.976

9.  Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity Intervention.

Authors:  Ryan D Nipp; Hang Lee; Emily Gorton; Morgan Lichtenstein; Salome Kuchukhidze; Elyse Park; Bruce A Chabner; Beverly Moy
Journal:  Oncologist       Date:  2019-04-15

10.  Effectiveness of informational decision aids and a live donor financial assistance program on pursuit of live kidney transplants in African American hemodialysis patients.

Authors:  L Ebony Boulware; Patti L Ephraim; Jessica Ameling; LaPricia Lewis-Boyer; Hamid Rabb; Raquel C Greer; Deidra C Crews; Bernard G Jaar; Priscilla Auguste; Tanjala S Purnell; Julio A Lamprea-Monteleagre; Tope Olufade; Luis Gimenez; Courtney Cook; Tiffany Campbell; Ashley Woodall; Hema Ramamurthi; Cleomontina A Davenport; Kingshuk Roy Choudhury; Matthew R Weir; Donna S Hanes; Nae-Yuh Wang; Helene Vilme; Neil R Powe
Journal:  BMC Nephrol       Date:  2018-05-03       Impact factor: 2.388

View more
  1 in total

1.  Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment.

Authors:  Emeline M Aviki; Bridgette Thom; Kenya Braxton; Andrew J Chi; Beryl Manning-Geist; Fumiko Chino; Carol L Brown; Nadeem R Abu-Rustum; Francesca M Gany
Journal:  Support Care Cancer       Date:  2021-11-25       Impact factor: 3.359

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.